Skip to content

Triggering Ovulation at Follicle Size Smaller or Larger Than 17mm in a Modified Natural Cycle

Triggering Ovulation at Follicle Size Smaller or Larger Than 17mm in a Modified Natural Cycle

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07088952
Acronym
17FET
Enrollment
572
Registered
2025-07-28
Start date
2025-10-22
Completion date
2028-05-30
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Embryo Transfer

Keywords

Natural Cycle, Frozen Embryo Transfer, Follicle Size, Pregnancy, Implantation

Brief summary

The rise in frozen embryo transfer (FET) cycles within assisted reproductive technology (ART) has sparked the need to refine endometrial preparation protocols. The switch from hormone replacement cycles (HRT) to natural cycles, poses scheduling challenges onto laboratories, doctors and patients. The modified natural cycle (mNC), offering more precision for scheduling, shows promise but lacks comprehensive data on the potential flexibility of triggering criteria that may allow to control timing in a wider range. This prospective randomized study seeks to address this knowledge gap by evaluating the non-inferiority of triggering ovulation in mNC with follicle diameters of 13-16.9mm compared to the conventional 17-22mm. The study aims to enhance the understanding of the impact of follicle size at ovulation in reproductive outcomes, optimize FET treatments providing a more flexible mNC protocol, and improve patient care in ART clinics.

Interventions

PROCEDURETrigger at smaller folicular size

Trigger indicated at folicular diameter smaller than standard clinical practice, from 13mm to 16.9mm

Sponsors

Vida Recoletas Sevilla
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective open randomized parallel group 1:1 ratio

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* At least one expanded blastocyst (regardless of its quality) * Spontaneous menstrual cycles * Consent to undergo frozen embryo transfer in a modified natural cycle

Exclusion criteria

* Abnormal uterine cavity * Fluid in endometrial cavity

Design outcomes

Primary

MeasureTime frameDescription
Pregnancy rateFrom embryo transfer up to 2 weeks laterRate of positive pregnancies over total transfers performed, according to beta-test result

Secondary

MeasureTime frameDescription
Implantation rateup to 8 weeks of gestational ageImplantation rate, defined as number of gestational sacs per embryos transferred
Cancelation ratePerioperative/PeriproceduralNumber of cancelled embryo transfers per initiated endometrial preparation cycles. Transfer canceling implies end of study.
Miscarriage rateFrom embryo transfer to delivery, up to 40 weeksNumber of miscarriages of any type registered after transfer during the study, per total number of transfers performed

Countries

Spain

Contacts

Primary ContactManuel Fernández Sánchez, MD PhD
vida.investiga@gruporecoletas.com+34954286274
Backup ContactClara Palacio de Marco, MSc
clara.palacio@gruporecoletas.com+34954286274

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026